Susquehanna International »

Oruka Therapeutics shares owned by Susquehanna International

Quarter-by-quarter ownership of Oruka Therapeutics shares owned by Susquehanna International from 13F filings

Historical chart of Susquehanna International investment in Oruka Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oruka Therapeutics held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oruka Therapeutics by Susquehanna International

Quarter filed Position value Share count Share price at filing
2024-09-30 $306k 13k 24.51

More positions owned by Susquehanna International

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Tr Russell 2000 Etf (IWM)
Meta Platforms Cl A (META)
Amazon (AMZN)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Costco Wholesale Corporation (COST)
Advanced Micro Devices (AMD)
Netflix (NFLX)

View all positions for Susquehanna International

Top funds holding Oruka Therapeutics

Fairmount Funds Management
VR Adviser
Commodore Capital
Perceptive Advisors
Avidity Partners Management
Franklin Resources
Paradigm Biocapital Advisors
Braidwell
Dr. Jeffrey R. Jay, M.D.
Point72 Asset Management
Frazier Life Sciences Management
Redmile Group
Woodline Partners
Affinity Asset Advisors
Driehaus Capital Management

View all funds holding Oruka Therapeutics